BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Praveen Eadala. Clinical Pathways in Emergency Medicine2016; : 375 doi: 10.1007/978-81-322-2710-6_30
2
George E. Fragoulis, Fotini N. Skopouli, Carlo Selmi, M. Eric Gershwin. Sjögren’s Syndrome2011; : 237 doi: 10.1007/978-0-85729-947-5_17
3
R. Liberal, G. Mieli-Vergani, D. Vergani. Autoimmune hepatitis: From mechanisms to therapyRevista Clínica Española 2016; 216(7): 372 doi: 10.1016/j.rce.2016.04.003
4
Gert Hausdorf, Dirk Roggenbuck, Eugen Feist, Thomas Büttner, Peter R. Jungblut, Karsten Conrad, Christoph Berg, Reinhild Klein. Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA—Revival of a disease-activity marker in autoimmune hepatitisClinica Chimica Acta 2009; 408(1-2): 19 doi: 10.1016/j.cca.2009.06.035
5
Leon D. Averbukh, George Y. Wu. Role of Biologics in the Development of Autoimmune Hepatitis: A ReviewJournal of Clinical and Translational Hepatology 2018; 6(4): 1 doi: 10.14218/JCTH.2018.00039
6
Asli Gamze Sener. Autoantibodies in autoimmune liver diseasesAPMIS 2015; 123(11): 915 doi: 10.1111/apm.12442
7
YI LI, MILIN PENG, GUOZHONG GONG. Evaluation of the revised versus the simplified scoring system in patients with autoimmune hepatitisExperimental and Therapeutic Medicine 2014; 7(1): 131 doi: 10.3892/etm.2013.1366
8
Marta Casal Moura, Rodrigo Liberal, Hélder Cardoso, Ana Maria Horta e Vale, Guilherme Macedo. Management of autoimmune hepatitis: Focus on pharmacologic treatments beyond corticosteroidsWorld Journal of Hepatology 2014; 6(6): 410-418 doi: 10.4254/wjh.v6.i6.410
9
Mieke M.H. Lamers, Martijn G.H. van Oijen, Martine Pronk, Joost P.H. Drenth. Treatment options for autoimmune hepatitis: A systematic review of randomized controlled trialsJournal of Hepatology 2010; 53(1): 191 doi: 10.1016/j.jhep.2010.01.037
10
Rodrigo Liberal, Charlotte R. Grant, Giorgina Mieli-Vergani, Diego Vergani. Autoimmune hepatitis: A comprehensive reviewJournal of Autoimmunity 2013; 41: 126 doi: 10.1016/j.jaut.2012.11.002
11
Simon Pape, Tom J.G. Gevers, Jan Maarten Vrolijk, Bart van Hoek, Gerd Bouma, Carin M.J. van Nieuwkerk, Richard Taubert, Elmar Jaeckel, Michael P. Manns, Maria Papp, Nora Sipeki, Felix Stickel, Cumali Efe, Ersan Ozaslan, Tugrul Purnak, Frederik Nevens, Dominik J.N. Kessener, Alisan Kahraman, Heiner Wedemeyer, Johannes Hartl, Christoph Schramm, Ansgar W. Lohse, Joost P.H. Drenth, Michael A. Heneghan. Rapid Response to Treatment of Autoimmune Hepatitis Associated With Remission at 6 and 12 MonthsClinical Gastroenterology and Hepatology 2020; 18(7): 1609 doi: 10.1016/j.cgh.2019.11.013
12
Gloria Flamenco, Margot Hall, Anna K. Swann. Case Study and Review of Autoimmune HepatitisLaboratory Medicine 2013; 44(1): 79 doi: 10.1309/LML0OPQA9YD8TVGY
13
Rodrigo Liberal, Charlotte R. Grant, Maria Serena Longhi, Giorgina Mieli-Vergani, Diego Vergani. Diagnostic criteria of autoimmune hepatitisAutoimmunity Reviews 2014; 13(4-5): 435 doi: 10.1016/j.autrev.2013.11.009
14
José V. Arcos-Machancoses, Cristina Molera Busoms, Ecaterina Julio Tatis, María V. Bovo, Javier Martín de Carpi. Accuracy of the Simplified Criteria for Autoimmune Hepatitis in Children: Systematic Review and Decision AnalysisJournal of Clinical and Experimental Hepatology 2019; 9(2): 147 doi: 10.1016/j.jceh.2018.10.006
15
José Vicente Arcos-Machancoses, Cristina Molera Busoms, Ecaterina Julio Tatis, María Victoria Bovo, Jesús Quintero Bernabeu, Javier Juampérez Goñi, Vanessa Crujeiras Martínez, Javier Martín de Carpi. Development and validation of a new simplified diagnostic scoring system for pediatric autoimmune hepatitisDigestive and Liver Disease 2019; 51(9): 1308 doi: 10.1016/j.dld.2019.02.018
16
Giorgina Mieli-Vergani, Rodrigo Liberal, Diego Vergani. Liver Immunology2014; : 361 doi: 10.1007/978-3-319-02096-9_24
17
Karen L. Krok, Santiago J. Munoz. Management of Autoimmune and Cholestatic Liver DisordersClinics in Liver Disease 2009; 13(2): 295 doi: 10.1016/j.cld.2009.02.011
18
Diego Vergani, Rodrigo Liberal, Giorgina Mieli-Vergani. Liver Immunology2014; : 281 doi: 10.1007/978-3-319-02096-9_19
19
Pietro Invernizzi. Geoepidemiology of autoimmune liver diseasesJournal of Autoimmunity 2010; 34(3): J300 doi: 10.1016/j.jaut.2009.12.002
20
Joshua F. Zeidner, Emily Sydnor. Painless JaundiceThe American Journal of Medicine 2010; 123(7): 601 doi: 10.1016/j.amjmed.2010.03.007
21
Kiyoshi Migita, Yukio Watanabe, Yuka Jiuchi, Yoko Nakamura, Akira Saito, Michiyasu Yagura, Hideo Morimoto, Masaaki Shimada, Eiji Mita, Taizo Hijioka, Haruhiro Yamashita, Eiichi Takezaki, Toyokichi Muro, Hironori Sakai, Makoto Nakamuta, Seigo Abiru, Koji Yano, Atsumasa Komori, Hiroshi Yatsuhashi, Minoru Nakamura, Hiromi Ishibashi. Evaluation of risk factors for the development of cirrhosis in autoimmune hepatitis: Japanese NHO-AIH prospective studyJournal of Gastroenterology 2011; 46(S1): 56 doi: 10.1007/s00535-010-0337-y
22
Heiko Schotte, Peter Willeke, Johanna Schmalhorst, Bernhard Schlüter. Diagnostic Performance of an Anti-Actin Autoantibody Binding Enzyme Immunodot Blot in Autoimmune Hepatitis Type 1Journal of Clinical Laboratory Analysis 2016; 30(2): 123 doi: 10.1002/jcla.21825
23
Nathaniel S Rial, Kevin B Gilchrist, Jeff T Henderson, Achyut K Bhattacharyya, Thomas D Boyer, Abdul Nadir, John T Cunningham. Endoscopic ultrasound with biopsy of omental mass for cholangiocarcinoma diagnosis in cirrhosisWorld Journal of Gastrointestinal Endoscopy 2011; 3(6): 124-128 doi: 10.4253/wjge.v3.i6.124
24
R. Liberal, G. Mieli-Vergani, D. Vergani. Autoimmune hepatitis: From mechanisms to therapyRevista Clínica Española (English Edition) 2016; 216(7): 372 doi: 10.1016/j.rceng.2016.04.004
25
Guangtao Xia, Sensen Wu, Yuanchao Zhang. Anti-4-1BB monoclonal antibodies attenuate concanavalin A-induced immune-mediated liver injury in miceExperimental and Therapeutic Medicine 2016; 12(3): 1263 doi: 10.3892/etm.2016.3503
26
Navchetan Kaur, Ranjana W. Minz, Shashi Anand, Biman Saikia, Ritu Aggarwal, Ashim Das, Babu R. Thapa, Yogesh K. Chawla. HLA DRB1 Alleles Discriminate the Manifestation of Autoimmune Hepatitis as Type 1 or Type 2 in North Indian PopulationJournal of Clinical and Experimental Hepatology 2014; 4(1): 14 doi: 10.1016/j.jceh.2013.12.002
27
Ming Hong, Sha Li, Hor Tan, Ning Wang, Sai-Wah Tsao, Yibin Feng. Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future ProspectsInternational Journal of Molecular Sciences 2015; 16(12): 28705 doi: 10.3390/ijms161226126
28
Jeni Page ACNP-BC. Nonalcoholic fatty liver disease: The hepatic metabolic syndromeJournal of the American Academy of Nurse Practitioners 2012; 24(6): 345 doi: 10.1111/j.1745-7599.2012.00716.x
29
Rodrigo Liberal, Giorgina Mieli-Vergani, Diego Vergani. Contemporary issues and future directions in autoimmune hepatitisExpert Review of Gastroenterology & Hepatology 2016; 10(10): 1163 doi: 10.1080/17474124.2016.1193004
30
José Vicente Arcos-Machancoses, Cristina Molera Busoms, Ecaterina Julio Tatis, María Victoria Bovo, Jesús Quintero Bernabeu, Javier Juampérez Goñi, Vanessa Crujeiras Martínez, Javier Martin de Carpi. Accuracy of the 2008 Simplified Criteria for the Diagnosis of Autoimmune Hepatitis in ChildrenPediatric Gastroenterology, Hepatology & Nutrition 2018; 21(2): 118 doi: 10.5223/pghn.2018.21.2.118
31
Miray Karakoyun, Cigdem O. Ecevit, Erhan Kilicoglu, Sema Aydogdu, Rasit V. Yagci, Funda Ozgenc. Autoimmune hepatitis and long-term disease course in children in Turkey, a single-center experienceEuropean Journal of Gastroenterology & Hepatology 2016; 28(8): 927 doi: 10.1097/MEG.0000000000000648
32
Andreas E Kremer, Christian Rust, Peter Eichhorn, Ulrich Beuers, Stefan Holdenrieder. Immune-mediated liver diseases: programmed cell death ligands and circulating apoptotic markersExpert Review of Molecular Diagnostics 2009; 9(2): 139 doi: 10.1586/14737159.9.2.139